Autoimmune necrotising myopathy (Q84062): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1655474050 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_1655474050
Property / CURIE: CID11:ID_1655474050 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_1655474050
Property / Canary Token: dki-india-ID_1655474050 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 09:25, 15 August 2026

Presents with proximal muscle weakness occurring during or after treatment with statins; often associated with elevated serum creatine kinase (CK). The muscle weakness can persist, after discontinuation of statin treatment. Neuropathologically gives evidence of necrotizing myopathy with scarce inflammation. Immune suppressive therapy may be needed. Associated neural autoantibodies are Anti- SRP (signal recognition particle antibody) and anti HMGCR (Autoantibodies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Language Label Description Also known as
default for all languages
ID_1655474050
    English
    Autoimmune necrotising myopathy
    Presents with proximal muscle weakness occurring during or after treatment with statins; often associated with elevated serum creatine kinase (CK). The muscle weakness can persist, after discontinuation of statin treatment. Neuropathologically gives evidence of necrotizing myopathy with scarce inflammation. Immune suppressive therapy may be needed. Associated neural autoantibodies are Anti- SRP (signal recognition particle antibody) and anti HMGCR (Autoantibodies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase)

      Statements

      CID11:ID_1655474050
      0 references
      dki-india-ID_1655474050
      0 references
      Concluído
      0 references
      13 August 2026
      0 references